Anbio Biotechnology Cash Flow Statement (2024-2025) | NNNN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2024	Jun2025
Operating Activities
Change in Working Capital
Change in Account Payables (Quarter)	1,625.26B	60.35B
Change in Accured Expenses (Quarter)	104.98B	70.78B
Other Working Capital Changes (Quarter)	25.61B	362.16B